帝王切開の術後疼痛管理
帝王切開の術後疼痛管理:前向き観察コホート研究
Caesarean section is one of the most frequent surgeries causing severe postoperative pain. Poor management of acute pain can contribute to postoperative complications, late recovery and the development of chronic pain. Moreover, it had been demonstrated that the intensity of postpartum pain is associated with depression. It is imperative to find out appropriate methods of postpartum pain alleviation. Currently, a lot of analgesic drugs and methods have been developed and used in clinical practice, such as patient-controlled analgesia, extended-release analgesics and multimodal analgesia. This prospective cohort study is aimed to investigate the outcome of each postoperative analgesic method used in caesarean section.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
This is a prospective, observational, cohort study. Patients undergoing elective caesarean section will be invited to the study. The written informed consent will be obtained prior to participation. After getting the written informed consent, data will be collected from medical records, questionnaires, patient diaries, visit records and telephone visit records. Through telephone visits, postpartum depression scale and postpartum chronic pain will be evaluated six weeks and three months after delivery. Demographic data, consumption of analgesics, analgesic methods, intensity of postoperative pain, complications, recovery time, score of depression scale will all be summarized. Numerical variables will be present with mean and standard deviation and categorical variables will be present with number and percentage.
研究の種類
研究の種類
入学 (実際)
入学
連絡先と場所
研究場所
-
-
-
New Taipei City、台湾、251
- MacKay Memorial Hospital Tamsui Branch
-
Taipei、台湾、104
- MacKay Memorial Hospital
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Pregnant woman scheduled to have caesarean section within 30 days.
説明
Inclusion Criteria:
- Aged 20 to 40.
- Planing to undergo caesarean section with spinal anesthesia.
- Scheduled to undergo cesarean section between 37 and 40 weeks of gestation.
- American Society of Anesthesiology Physical Class 1-2.
- Planing to alleviate postoperative pain with intravenous patient-controlled analgesia or administration of NALDEBAIN.
Exclusion Criteria:
- Not willing to provide informed consent.
- Unable to receive opioids or NSAIDs due to contraindication.
- Long-term use of opioids or drug abuse.
- Suffering from chronic pain disease.
- Having medical history of mental illnesses.
- Diagnosed with Pre-eclampsia or eclampsia.
- Diagnosed with gestational diabetes.
- Unsuitable for participation judged by investigator.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
グループ/コホートの数
コホートと介入
グループ/コホートグループ/コホート |
介入・治療介入・治療 |
|---|---|
|
IV-PCA + NALDEBAIN group
Patients treated with the combination of IV-PCA and intramuscular injection of dinalbuphine sebacate will be allocated to IV-PCA + NALDEBAIN group. |
At the two trial sites, IV-PCA is commonly used with morphine. The device is installed after delivery and removed within 3 days.
他の名前:
Dinalbuphine sebacate is a prodrug of nalbuphine. With oil-based formulation, the active ingredient releases slowly and the effect lasts longer than nalbuphine. After delivery, a single 150 mg dose of dinalbuphine sebacate is administered intramuscularly.
他の名前:
|
|
IV-PCA group
Patients receiving intravenous patient-controlled analgesia (IV-PCA) will be allocated to IV-PCA group. |
At the two trial sites, IV-PCA is commonly used with morphine. The device is installed after delivery and removed within 3 days.
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Postpartum pain intensity
時間枠:Within 5 days after delivery
|
Pain intensity is assessed by numerical rating scale (NRS) at least twice daily during hospital stay after delivery. NRS is a 11-point scale which labeled from zero (no pain) to ten (worst pain). The area under the curve of NRS are calculated. |
Within 5 days after delivery
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Consumption of analgesics
時間枠:Within 5 days after delivery
|
The mean total consumption of analgesics during the hospital stay after delivery. |
Within 5 days after delivery
|
|
Incidence of complications
時間枠:Up to 5 days after delivery
|
the incidence of postoperative complication occurring during hospital stay after delivery, especially the ones related to analgesics. |
Up to 5 days after delivery
|
|
Ambulation
時間枠:Up to 5 days after delivery
|
The mean length of time between delivery and the first ambulation. |
Up to 5 days after delivery
|
|
Breastfeeding
時間枠:Up to 5 days after delivery
|
The percentage of participants able to breastfeed during hospital stay and the mean length of time between delivery and the first breastfeeding. |
Up to 5 days after delivery
|
|
Gastrointestinal function recovery
時間枠:Up to 5 days after delivery
|
The mean length of time between delivery and first soft diet. |
Up to 5 days after delivery
|
|
Postnatal Depression assessment
時間枠:At baseline, 6 weeks and 3 months after delivery
|
Edinburgh Postnatal Depression questionnaire is used to assess patients' postpartum depression. Participants are asked to fill in the questionnaire at baseline (within 30 days prior to delivery), 6 weeks and 3 months after delivery. |
At baseline, 6 weeks and 3 months after delivery
|
|
Satisfaction assessed by a four-point scale
時間枠:6 weeks after delivery
|
Participants are asked to assess the satisfaction toward rate of recovery progress and pain management through 6 questions six weeks after delivery. Each question contain 4 choices: very satisfied, satisfied, dissatisfied and very dissatisfied. |
6 weeks after delivery
|
|
Chronic pain intensity
時間枠:6 weeks and 3 months after delivery
|
Chronic pain intensity is assessed by NRS 6 weeks and 3 months after delivery. NRS is a 11-point scale which labeled from zero (no pain) to ten (worst pain). |
6 weeks and 3 months after delivery
|
協力者と研究者
捜査官
捜査官
- 主任研究者:Chi-Hsu Wang, M.D.、MacKay Memorial Hospital Tamsui Branch
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (実際)
一次修了
研究の完了 (実際)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- 21MMHIS203e
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。